About

Biogen Inc. is an American multinational biotechnology company, founded in 1978 and headquartered in Cambridge, Massachusetts, United States. Specializing in the discovery, development, and delivery of treatments for neurological diseases to patients worldwide, this public company reported US$ 9.676 billion in revenue in 2024. Biogen maintains a significant global presence, operating in countries including Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland.